As of Q1 2023, Dr Reddys Laboratories's earnings has grown 31.71% year over year. This is 27.84 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 3.87%. Dr Reddys Laboratories's earnings in the past year totalled $300.61 million.
As of Q1 2023, Dr Reddys Laboratories's revenue has grown 8.85% year over year. This is 217.43 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 226.28%. Dr Reddys Laboratories's revenue in the past year totalled $2.73 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.